Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alex E. Peluffo"'
Autor:
Xu Li, Jinchao Yu, Zhiming Zhang, Jing Ren, Alex E. Peluffo, Wen Zhang, Yujie Zhao, Jiawei Wu, Kaijing Yan, Daniel Cohen, Wenjia Wang
Publikováno v:
Medicine in Drug Discovery, Vol 10, Iss , Pp 100090- (2021)
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodyn
Externí odkaz:
https://doaj.org/article/25ea1c2faf6c46a6a612bc321e443bfe
Autor:
Wen Zhang, Daniel Cohen, Wenjia Wang, Jiawei Wu, Yujie Zhao, Jinchao Yu, Kaijing Yan, Xu Li, Jing Ren, Alex E. Peluffo, Zhiming Zhang
Publikováno v:
Medicine in Drug Discovery, Vol 10, Iss, Pp 100090-(2021)
Medicine in Drug Discovery
Medicine in Drug Discovery
The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodyn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b574a5de5bcca1003d41602878f6267a
http://www.sciencedirect.com/science/article/pii/S2590098621000117
http://www.sciencedirect.com/science/article/pii/S2590098621000117
Autor:
Wen Zhang, Wenjia Wang, Daniel Cohen, Kaijing Yan, Xu Li, Yujie Zhao, Alex E. Peluffo, Jinchao Yu, Zhiming Zhang, Jing Ren
The COVID-2019 disease caused by the SARS-CoV-2 virus (aka 2019-nCoV) has raised significant health concerns in China and worldwide. While novel drug discovery and vaccine studies are long, repurposing old drugs against the COVID-2019 epidemic can he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3a3797f71ca87305bc9991cc2ada326
Autor:
Philippe Rinaudo, Serguei Nabirotchkin, Jinchao Yu, Alex E. Peluffo, Rodolphe Hajj, Daniel Cohen
Publikováno v:
Current opinion in pharmacology. 51
Drug repurposing has attracted increased attention, especially in the context of drug discovery rates that remain too low despite a recent wave of approvals for biological therapeutics (e.g. gene therapy). These new biological entities-based treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4deef1e97a3bc5677a20a13dda627848
https://pubmed.ncbi.nlm.nih.gov/31982325
https://pubmed.ncbi.nlm.nih.gov/31982325